Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dementia01:30

Dementia

482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The association between passion, disordered eating attitudes, and self-reported injuries among pre-professional contemporary and ballet dancers.

Acta psychologica·2026
Same author

Speech as a dynamic biomarker of physical aging: a longitudinal study.

GeroScience·2026
Same author

Mood and Age Predict Cognitive Complaints in Memory Clinic Patients: A Machine-Learning and Linear Modeling Approach.

European journal of neurology·2026
Same author

Speech-based digital biomarkers for early etiological stratification of Alzheimer's disease and frontotemporal degeneration: a biomarker-confirmed prospective study.

The journal of prevention of Alzheimer's disease·2026
Same author

A Scale for Older adults' decisional balance regarding physical ACTIVity (SO-ACTIV): development and validation in a French sample.

Frontiers in public health·2026
Same author

Spontaneous speech enables scalable digital phenotyping of physical functional deficits in aging.

npj aging·2026

相关实验视频

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

技术与痴呆症 会议前会议

Eloïse DA Cunha1,2,3,4, Valeria Manera2, Raphael Zory5

  • 1Speech and Language Pathology Department, Université Côte d'Azur, Nice, Alpes Maritimes, France.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
PubMed
概括

语音分析可以准确地识别阿尔茨海默病 (AD) 现象型和潜在病理,为早期预后提供一种非侵入性工具. 这种方法有助于完善诊断和改善神经退行性疾病的早期干预策略.

更多相关视频

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

相关实验视频

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

科学领域:

  • 神经科学是一个神经科学.
  • 计算语言学 计算语言学
  • 生物标志物发现发现

背景情况:

  • 阿尔茨海默病 (AD) 呈现出不同的临床形式,需要量身定制的护理.
  • 洛戈佩尼克变异原发性渐进性失语症 (lvPPA) 的预后是具有挑战性的,因为不同的潜在病理 (AD或FTLD).
  • 准确的诊断需要多学科的方法,包括CSF分析,成像和心理测量评估.

研究的目的:

  • 评估语音标志物,以与大脑脊髓液 (CSF) 档案进行AD表型的交叉分类.
  • 开发一种非侵入性方法,用于早期诊断神经退行性疾病的进展.
  • 区分临床表型和基础病理在早期的AD.

主要方法:

  • 42名患者被分为lvPPA- (FTLD),lvPPA+ (AD) 和AD组.
  • 来自14句重复任务的语音录音被分析为prosodic和时间特征.
  • 监督机器学习模型 (随机森林,KNN,SVM) 被训练并验证为分类.

主要成果:

  • 随机森林模型实现了91%的交叉验证准确度,优于其他模型.
  • 基于语音的分类成功地区分了lvPPA-, lvPPA+和AD组.
  • 研究结果表明,语音分析是一种有价值的非侵入性工具,可用于早期预后识别阿尔茨海默病的表型和病理.

结论:

  • 基于语音的分类将临床表型与CSF概况联系起来,提供早期预后见解.
  • 提高预后精度可以改善阿尔茨海默病的早期干预策略.
  • 需要进行更大规模的研究来验证语音分类作为差异预后的可靠的非侵入性工具.